Position in PFE
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$290,356
-$39,836 QoQ
Shares Held
12,058
+2.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#2,149
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INVESTMENT ADVISORY SERVICES INC /TX /ADV holds $16,555,030 across 7 Drug Manufacturers - General names. PFE ranks #6 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,036 | $6,612,362 | |
| 2 | ABBV |
AbbVie Inc.
|
24,722 | $6,221,044 | |
| 3 | AMGN |
Amgen Inc
|
5,246 | $1,899,681 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,465 | $959,252 | |
| 5 | LLY |
ELI LILLY & Co
|
296 | $355,031 | |
| 6 | PFE |
Pfizer Inc
This page
|
12,058 | $290,356 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,720 | $217,304 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $290,356 | 12,058 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $330,192 | 11,759 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $289,860 | 11,641 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $287,720 | 11,292 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $265,355 | 10,947 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $288,901 | 11,401 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $301,646 | 11,370 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $276,261 | 9,546 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $316,090 | 11,297 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $338,550 | 12,200 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $347,840 | 12,082 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $666,617 | 20,097 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $725,236 | 19,772 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $684,909 | 16,787 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $887,118 | 17,313 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $757,923 | 17,320 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $903,526 | 17,233 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $824,799 | 15,932 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $940,725 | 15,931 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $749,707 | 17,431 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $685,417 | 17,503 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $619,328 | 16,825 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $558,720 | 15,224 | Shares | Sole | 2021-03-10 | |
| 2020-06-30 | $481,998 | 14,740 | Shares | Sole | 2021-03-10 | |
| 2020-03-31 | $340,010 | 10,417 | Shares | Sole | 2021-03-10 | |
| No filing history on record for this holder in this stock. | ||||||